Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [ID6444]

  • Awaiting development
  • GID-TA11560
  • Expected publication date: TBC

27353-Zolbetuximab-Nab-paclitaxel-Gemcitabine-for-Pancreatic-Adenocarcinoma-V1.0-APR2024-NON-CONF.pdf (nihr.ac.uk)